Keyphrases
Small Interfering RNA (siRNA)
100%
Dendritic Cells
100%
Tumor Antigen
100%
Antigen-specific
100%
Transforming Growth Factor Receptor
100%
CD8+ T Cell Immunity
100%
Interleukin-10 Receptor
100%
Transforming Growth Factor-β
27%
TC-1
27%
MiRNA Target
27%
Interleukin-10
18%
Immunosuppressive Molecules
18%
Tumor Model
18%
IL-10 Receptor
18%
Immunosuppressive Factors
18%
Tumor
9%
Cancer Immunotherapy
9%
Immune Response
9%
Tumor Cells
9%
Cell-based
9%
Therapeutic Agents
9%
Chromosome 10
9%
Phosphatase
9%
Tensin Homolog
9%
Antitumor Effect
9%
HPV16
9%
Cervical Cancer
9%
Knockdown
9%
CD8+ T Cells
9%
Immune Cells
9%
E7 Antigen
9%
Clinical Development
9%
Interleukin
9%
Cancer Model
9%
Immunoadjuvant
9%
Immune Priming
9%
TGF-β Receptor
9%
Endogenous Substances
9%
Co-target
9%
Sorting out
9%
Bcl-2-like Protein 11
9%
Medicine and Dentistry
Cytotoxic T-Cell
100%
Small Interfering RNA
100%
Cellular Immunity
100%
Tumor Antigen
100%
Dendritic Cell
100%
Interleukin 10 Receptor
100%
Growth Factor Receptor
100%
Cancer Growth Factor
100%
Immunosuppressive Drug
36%
Interleukin 10
36%
Neoplasm
18%
Antigen Specificity
18%
Immunity
18%
Tumor Model
18%
Alpha Adrenergic Receptor
18%
Cancer Immunotherapy
9%
Immune Response
9%
Cancer Model
9%
Therapeutic Agent
9%
Receptor
9%
Tumor Cell
9%
Immunocompetent Cell
9%
Cervical Cancer
9%
Human Papillomavirus Type 16
9%
Cytokine
9%
Phosphatidylinositol 3,4,5 Trisphosphate 3 Phosphatase
9%
Dendritic Cell Vaccine
9%
Interleukin 10 Receptor Alpha
9%
BIM Protein
9%
Immunological Adjuvant
9%
Immunology and Microbiology
Tumor Antigen
100%
Dendritic Cell
100%
Adoptive Immunity
100%
Cytotoxic T-Cell
100%
Interleukin-10 Receptor
100%
Cancer Growth Factor
100%
Interleukin 10
50%
Immunosuppressive Drug
50%
Antigen Specificity
25%
Immunity
25%
Immune Response
12%
Cancer Immunotherapy
12%
Tumor Cell
12%
Human Papillomavirus Type 16
12%
Cytokine
12%
Immunocompetent Cell
12%
Dendritic Cell Vaccine
12%
Bcl-2
12%
Interleukin
12%
Immunologic Adjuvant
12%
Interleukin 10 Receptor, Alpha Subunit
12%
Chromosome 10
12%
Pharmacology, Toxicology and Pharmaceutical Science
Small Interfering RNA
100%
CD8 Antigen
100%
Tumor Antigen
100%
Interleukin 10 Receptor
100%
Growth Factor Receptor
100%
Cancer Growth Factor
100%
Interleukin 10
36%
Immunosuppressive Agent
36%
Neoplasm
27%
Tumor Model
18%
Alpha Adrenergic Receptor
18%
Malignant Neoplasm
9%
Cancer Model
9%
Immunotherapy
9%
Cytokine
9%
Phosphatidylinositol 3,4,5 Trisphosphate 3 Phosphatase
9%
Receptor
9%
Human Papillomavirus Type 16
9%
Uterine Cervix Cancer
9%
Dendritic Cell Vaccine
9%
Immunologic Adjuvant
9%
BIM Protein
9%
Interleukin 10 Receptor Alpha
9%